Described are pharmaceutical compositions comprising phentermine metformin and at least one pharmaceutically acceptable carrier or excipient. Another aspect of the present invention relates to a method of treating a patient suffering from obesity or needing to lose weight comprising the step of co-administering to said patient a therapeutically effective amount of phentermine and metformin. In certain embodiments an aforementioned method is practiced in conjunction or tandem with a medical proce...

A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in immediate release form, in a daily dose in the range of 2 mg to 8 mg, in combination with a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone. Methods for treating obesity, conditions associated with obesity, and other indications are also provided, as are compositions and dosage forms containing low do...

A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in immediate release form in a daily dose in the range of 2 mg to 8 mg in combination with a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone. Methods for treating obesity conditions associated with obesity and other indications are also provided as are compositions and dosage forms containing low doses o...

A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in immediate release form in a daily dose in the range of 2 mg to 8 mg in combination with a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone. Methods for treating obesity conditions associated with obesity and other indications are also provided as are compositions and dosage forms containing low doses o...

A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in immediate release form in a daily dose in the range of 2 mg to 8 mg in combination with a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone. Methods for treating obesity conditions associated with obesity and other indications are also provided as are compositions and dosage forms containing low doses o...

This invention relates to a pharmaceutical composition comprising a combination of phentermine in an immediate-release form and topiramate in an extended-release form. Further it relates to processes for the preparation of the composition and a method of using the composition.

The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. In addition, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having Formula (I): or a pharmaceutically acceptable salt, solvate or hydrate thereof. These compositions are useful in pharmaceutical compositions whose use includes the treatment of obesity.

In one embodiment a layered pharmaceutical formulation includes two or more pharmaceutical layers and an intermediate layer disposed between at least two of the two or more pharmaceutical layers the intermediate layer configured to dissolve in vivo to thereby leave the two or more pharmaceutical layers substantially intact. In one embodiment an active pharmaceutical ingredient in at least one of the pharmaceutical layers is selected from bupropion zonisamide naltrexone topiramate phentermine met...

596881 Disclosed is a pharmaceutical composition liquid dosage form of phentermine (phenyl-tert-butylamine), said dosage form including a liquid carrier and suspended or dissolved therein one or more pharmaceutically active ingredient comprises one or more of phentermine HCl, and any other salt of Phentermine. Also disclosed is a Phentermine containing pharmaceutical composition administration apparatus, which apparatus includes a container and a dropper sized and dimensioned to permit a pharmac...